CENCORA: FORMERLY AMERISOURCEBERGEN
Cencora combines core pharmaceutical distribution with innovative business solutions to help our partners across the healthcare spectrum get medications to the patients who need them. Pharmaceutical manufacturers benefit from the global scale and resources of a company ranked #10 on the Fortune 500, combined with local expertise provided by more than 51,000 team members worldwide. Learn more at www.cencora.com.
Cencora has a proven history of bringing complex, transformative cell and gene therapies (CGTs) to market on a global scale. With end-to-end expertise in global strategies and key local markets, Cencora is ready to deliver strategic guidance along with implementation support across a broad array of functional areas. As a connected partner, Cencora is committed to navigating the patient and treatment journeys together with CGT manufacturers, no matter where they are in development.
CENCORA CELL AND GENE THERAPY EVENTS
ThinkLive Cell and Gene Therapy Virtual Summit 2025
Held May 20 – 21, 2025, this event gathered industry leaders, healthcare experts, and innovators to explore the latest advancements in cell and gene therapy. With over 30 speakers and 11 informative sessions across six tracks, the summit provided a platform for discussing critical topics such as the evolving regulatory landscape, patient support programs, and strategic partnerships aimed at enhancing patient access to therapies. Esteemed speakers shared their insights on the challenges faced by health systems in administering these innovative treatments and the importance of aligning patient services with real patient needs.
Watch On Demand
CELL & GENE THERAPIES
Your therapy can make all the difference. Together, we'll unlock its potential.
CONTACT INFORMATION
Cencora
1 W 1st Ave.
Conshohocken, PA 19428
UNITED STATES
FEATURED INSIGHTS
-
![GettyImages-1094847564-scientists-laboratory-flasks-planning-tablet]( "Essential Strategies For Mastering CMC And Avoiding CRLs For CGTs")
CGT developers face rising regulatory challenges around potency, stability, and process control. Find out how proactive planning, expert guidance, and early FDA engagement are key to avoiding delays.
-
![GettyImages-1072249434-lab-tablet]( "Why CMC Is A Key Sticking Point For CGTs And How To Meet FDA Expectations")
FDA scrutiny of CMC for cell and gene therapies is high. Learn common pitfalls—like issues with potency and comparability—and gain actionable strategies to meet regulatory expectations and reduce risk.
EXPLORE OUR THOUGHT LEADERSHIP
Explore the latest insights from the Cencora team.
VIDEOS AND WEBINARS
-
![Cencora - Orchestration]( "Connecting Manufacturers And Providers To The Services Needed For Full End-To-End Patient And Order Management")
Connecting Manufacturers And Providers To The Services Needed For Full End-To-End Patient And Order ManagementStreamline complex cell and gene therapy logistics with an integrated platform that connects manufacturers with vital services, providing full visibility and control for a more efficient and successful patient journey.
-
![Strategic Logistics]( "Crafting Scalable Solutions For Maximum Reach And Success")
Crafting Scalable Solutions For Maximum Reach And SuccessIs your supply chain ready for a blockbuster cell and gene therapy launch? Industry leaders discuss selecting partners, managing risk, and scaling operations for maximum reach and success.
-
![Maximizing Impact]( "Maximizing Impact: Strategies For Building Robust Patient Support Programs")
Maximizing Impact: Strategies For Building Robust Patient Support ProgramsPanelists explore the entire patient journey, from diagnosis to treatment, sharing strategies for creating practical, seamless support systems that ensure access to innovative cell and gene therapies.
-
![Navigating Special Regulatory Pathways For Advanced Therapy Development Success]( "Navigating Special Regulatory Pathways For Advanced Therapy Development Success")
Navigating Special Regulatory Pathways For Advanced Therapy Development SuccessDon't let regulatory hurdles slow you down. Learn from leading experts about special designations like RMAT and PRIME to accelerate your advanced therapy development and ensure success.
-
![The Power Of Integrated Distribution Strategies]( "The Power Of Integrated Distribution Strategies")
The Power Of Integrated Distribution StrategiesDiscover the power of integrated distribution for cell and gene therapies. Learn from expert speakers how adaptable partnerships can successfully bring these innovative treatments to more patients.
BLOGS
-
![GettyImages-1094847564-scientists-laboratory-flasks-planning-tablet]( "Essential Strategies For Mastering CMC And Avoiding CRLs For CGTs")
Essential Strategies For Mastering CMC And Avoiding CRLs For CGTsCGT developers face rising regulatory challenges around potency, stability, and process control. Find out how proactive planning, expert guidance, and early FDA engagement are key to avoiding delays.
-
![GettyImages-1072249434-lab-tablet]( "Why CMC Is A Key Sticking Point For CGTs And How To Meet FDA Expectations")
Why CMC Is A Key Sticking Point For CGTs And How To Meet FDA ExpectationsFDA scrutiny of CMC for cell and gene therapies is high. Learn common pitfalls—like issues with potency and comparability—and gain actionable strategies to meet regulatory expectations and reduce risk.
-
![GettyImages-1480473800 roadmap]( "Navigating Commercial Logistics For CGTs: A Roadmap To Scalable, Patient-Centered Success")
Navigating Commercial Logistics For CGTs: A Roadmap To Scalable, Patient-Centered SuccessThe commercialization of cell and gene therapies requires a precise and resilient logistics model that can adapt to rapid demand and global expansion while maintaining a patient-first approach.
-
![GettyImages-2193956924 supply chain, logistics]( "Navigating Commercial Logistics: Key Considerations For Emerging CGT Manufacturers")
Navigating Commercial Logistics: Key Considerations For Emerging CGT ManufacturersA successful cell and gene therapy launch requires a logistics strategy that keeps patients at the center, plans for disruptions, and prepares for future growth and global expansion.
-
![GettyImages-1089913166 lab]( "Discover The Path To Oncology Success")
Discover The Path To Oncology SuccessThe oncology landscape is brimming with innovative therapies and new treatment approaches. Successful commercialization requires a well-orchestrated strategy to bring these complex products to market.
